Akums Drugs IPO Allotment Status
Last Updated: 2nd August 2024 - 11:17 am
Summary
The Akums Drugs and Pharmaceuticals IPO was significantly oversubscribed, reaching a total of 185.82 times by August 1, 2024. The subscription details revealed robust interest across categories, with institutional investors subscribing 90.09 times, non-institutional investors 42.10 times, retail investors 20.77 times, and employees 4.13 times. On Day 2, the total subscription was 4.46 times, with institutional investors at 0.96 times, non-institutional investors at 8.50 times, retail investors at 9.09 times, and employees at 2.26 times. On Day 1, the IPO was subscribed 1.39 times, including 0.43 times by institutional investors, 1.97 times by non-institutional investors, 3.46 times by retail investors, and 1.11 times by employees.
Akums Drugs IPO Allotment Date - 02 August 2024
How to Check Akums Drugs IPO Allotment Status:
How to check Akums Drugs IPO allotment status on the Registrar site?
Step 1: Link Intime India Private Ltd.'s IPO registrar website can be accessed at https://linkintime.co.in/initial_offer/public-issues.html
Step 2: Choose the IPO from the dropdown menu; the name will be allocated after the allocation is complete.
Step 3: To view the current status, click on the application number, demat account, or PAN link.
Step 4: Select ASBA or non-ASBA under application type.
Step 5: Include information about the mode you selected in Step 2.
Step 6: Once you've completed the captcha, click submit.
How to check Akums Drugs and Pharmaceuticals IPO allotment status on BSE?
Step 1: Visit allotment page on BSE's official website- Akums Drugs and Pharmaceuticals IPO allotment status check online - https://www.bseindia.com/investors/appli_check.aspx
Step 2: Under 'Issue Type', select 'Equity'.
Step 3: Choose the IPO from the drop-down option under 'Issue Name'.
Step 4: Enter PAN or application number.
Step 5: Click 'I am not a Robot' to confirm your identity, then click the 'Submit' button.
How to check Akums Drugs IPO allotment status on NSE?
Step 1: Visit NSE's official website- Akums Drugs and Pharmaceuticals IPO allotment status check online NSE- https://www1.nseindia.com/products/dynaContent/equities/ipos/ipo_login.jsp\
Step 2: By selecting the 'Click here to sign up' option on the NSE website, one must register with PAN.
Step 3: Enter user name, password, and captcha code.
Step 4: Check IPO allotment status on the new page that will open.
How to Check Akums Drugs IPO Allotment Status in a Bank Account?
1. Log In to Your Internet Banking: Access your bank's website or mobile app and log in using your credentials.
2. Navigate to IPO Section: Look for a section related to "IPO Services" or "Application Status." This might be under an investment or services tab.
3. Enter Required Details: You may need to provide details such as your application number, PAN, or other identifiers.
4. Check Allotment Status: After entering the details, you should be able to see the IPO allotment status, indicating whether shares have been allotted or not.
5. Confirm the Status: For confirmation, you can cross-check the status with the Registrar of the IPO or use other sources.
How to Check Akums Drugs IPO Allotment Status in a Demat Account?
1. Log in to Your Demat Account: Access your Demat account through your Depository Participant's (DP) website or mobile app.
2. Locate IPO Section: Find the section related to "IPO" or "Portfolio." Look for any IPO-related entries or services.
3. Check IPO Allotment Status: Review the IPO section to see if the allotted shares are visible in your Demat account. This section usually shows the status of your IPO application.
4. Confirm with the Registrar: If the IPO shares are not visible, you can check the Registrar’s website by entering your application details to confirm the allotment.
5. Contact DP Support if Needed: For any discrepancies or issues, contact your DP's customer support for assistance.
3. Akums Drugs and Pharmaceuticals IPO Timelines:
IPO Open Date | July 30, 2024 |
IPO Close Date | August 1, 2024 |
Allotment Date | August 2, 2024 |
Initiation of Refunds | August 5, 2024 |
Credit of Shares to Demat | August 5, 2024 |
Listing Date | August 6, 2024 |
4. Akums Drugs IPO Subscription Status
Akums Drugs and Pharmaceuticals IPO subscribed 63.43 times. The public issue subscribed 20.77 times in the retail category, 90.09 times in QIB, and 42.10 times in the NII category by August 1, 2024 5:17:08 PM.
Akums Drugs IPO Subscription Day 3
-Total Subscription: 185.82 times.
-Institutional investors: 90.09 times.
-Non-institutional investors:42.10 times.
-Retail investors: 20.77 times.
-Employees: 4.13 times.
Akums Drugs IPO Subscription Day 2
-Total Subscription: 4.46 times.
-Institutional investors: 0.96 times.
-Non-institutional investors: 8.50 times.
-Retail investors: 9.09 times.
-Employees: 2.26 times.
Akums Drugs IPO Subscription Day 1
-Total Subscription: 1.39 times.
-Institutional investors: 0.43 times.
-Non-institutional investors: 1.97 times.
-Retail investors: 3.46 times.
-Employees: 1.11 times.
Akums Drugs and Pharmaceuticals IPO Details:
The Akums Drugs and Pharmaceuticals IPO, a book-built issue valued at ₹1,856.74 crores, includes a fresh issue of 1 crore shares worth ₹680 crores and an offer for sale of 1.73 crore shares totaling ₹1,176.74 crores. Subscriptions open from July 30, 2024, to August 1, 2024, with the allotment expected on August 2, 2024, and listing on BSE and NSE set for August 6, 2024. The price band is ₹646 to ₹679 per share, with a minimum lot size of 22 shares. The issue allocates 29.73% to QIBs, 14.87% to NIIs, 9.91% to RIIs, 0.89% to employees, and 44.60% to anchor investors, who have committed ₹828.78 crores.
Frequently Asked Questions
When is the Akums Drugs IPO Allotment Date?
What will be the Akums Drugs IPO Refund Date?
What is the chance of getting the Akums Drugs IPO Allotment?
How to check the Akums Drugs IPO Allotment Status?
How to check the Akums Drugs IPO Allotment via Registrar?
Akums Drugs IPO listing date?
Trending on 5paisa
Discover more of what matters to you.
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.